Urinalysis market to grow up to USD 6.2 billion by 2031

The global urinalysis market was valued at USD 3.4 billion in 2021 and it is anticipated to grow up to USD 6.2 billion by 2031, at a CAGR of 6.2% during the forecast period.

Urinalysis is also known as urine test that uses a urine sample to examine visual, chemical and microscopic aspects of urine to assess patient health. Urinalysis tests are commonly used by healthcare providers to check or monitor specific health disorders, damage to the kidney as well as to diagnose urinary tract infections.

Market trends and drivers
The growing geriatric population in developed and developing countries is anticipated to boost the market demand. The increasing prevalence of diabetes, liver, and renal diseases with aging will significantly contribute to the demand for urine tests in diagnosis. Incidence of such chronic conditions among elderly population lead to higher frequency of prescriptions for tests like creatinine, albumin, glucose, ketones, and bilirubin among others. According to the World Health Organization, the number of people aged 60 years and over is estimated to increase from 1 billion in 2020 to 1.4 billion by 2030. With increasing base of this age group, the industry is estimated to foresee tremendous growth. Additionally, higher risk of chronic kidney conditions with structural and functional changes in organs with aging will favour the testing volume.

Global urinalysis market segmentation
By product

• Consumables
  • Dipsticks
  • Reagents
  • Disposables
• Instruments
  • Biochemical Urine Analyzer
  • Automated Urine Sediment Analyzer

By application

• Urinary tract infections [UTI]
• Kidney disease
• Pregnancy
• Diabetes
• Others

By end-use

• Clinical laboratories
• Hospitals
• Home healthcare
• Others

By region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Major players in the global urinalysis market
The key players in the market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Sysmex Corporation (Japan), Quidel Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics (UK), Thermo Fisher Scientific Inc. (US), among others. Global Insight Services